Stocks and Investing Stocks and Investing
Mon, June 8, 2020
Fri, June 5, 2020

Matthew Luchini Initiated (VKTX) at Buy and Held Target at $14 on, Jun 5th, 2020


Published on 2024-10-27 07:45:18 - WOPRAI, Matthew Luchini
  Print publication without navigation


Matthew Luchini of BMO Capital, Initiated "Viking Therapeutics, Inc." (VKTX) at Buy and Held Target at $14 on, Jun 5th, 2020.

Matthew has made no other calls on VKTX in the last 4 months.



There are 3 other peers that have a rating on VKTX. Out of the 3 peers that are also analyzing VKTX, 0 agree with Matthew's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Matthew


  • Michael Morabito of "Chardan Capital" Initiated at Strong Buy and Held Target at $15 on, Tuesday, May 5th, 2020
  • Steven Seedhouse of "Raymond James" Maintained at Strong Buy with Decreased Target to $25 on, Friday, May 1st, 2020
  • Joseph Pantginis of "HC Wainwright & Co." Reiterated at Strong Buy with Decreased Target to $18 on, Thursday, February 27th, 2020
Contributing Sources